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ABSTRACT
Summary: We present a visualization tool applied on genome-
wide association data, revealing disease-associated haplotypes,
epistatically interacting loci, as well as providing visual signatures
of multivariate correlations of genetic markers with respect to a
phenotype.
Availability: Freely available on the web at: http://www.ee.columbia.
edu/∼anastas/sdplots
Contact: anastas@ee.columbia.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Linkage disequilibrium (LD) plots provide direct visualization of
pairwise associations of single nucleotide polymorphisms (SNPs).
They can be computed from large genotype sample sets, such as
those from the HapMap project, or from a genome-wide association
(GWA) study by plotting the matrix of association values for each
pair of SNPs.
LD plots have been used to identify blocks of SNPs associated
with a trait or disease for a given population (Duerr et al., 2006).
However, a more direct approach incorporates the presence of the
trait directly into the disequilibrium metric. The metric should
measure the amount of cooperative or redundant association of the
SNPs with the trait, allowing detection of ‘epistasis’, occurring
when the effects of a genetic factor on a trait is modiﬁed by
another factor. Given the limited success of identifying signiﬁcant
individual risk-conferring variants for some disorders, it is hoped
thatthediscoveryofresponsibleepistaticinteractionsamonggenetic
variants reﬂecting molecular elements in complex pathways will
elucidate novel disease mechanisms. The increasingly available
largebiologicaldatasetscomingfromGWAstudiesprovideaunique
opportunity to discover such multivariate correlations. Here we
provideasoftwarepackageintroducingsynergydisequilibrium(SD)
plots as visual tools identifying disease-associated haplotypes, as
well as epistatically interacting loci with respect to disease.
2 DESCRIPTION
Synergy is an information theoretic quantity well-suited for
discovering epistatic interactions. The synergy between two SNPs
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Si and Sj with respect to a disease C (or any phenotype or trait) is
deﬁned (Anastassiou, 2007) as the amount of information conveyed
by the pair of SNPs about the presence of the disease, minus the
sum of the corresponding amounts of information conveyed by each
SNP:
I(Si,Sj;C)−

I(Si;C)+I(Sj;C)

Thisisconsistentwiththedeﬁnition(AmericanHeritageDictionary)
of synergy as ‘the interaction of two or more agents or forces so
that their combined effect is greater than the sum of their individual
effects’.Thus, synergy quantiﬁes the amount of association between
two SNPs and a phenotype that is due to purely cooperative effects
among the factors. Equivalently, the synergy is equal to the increase
or decrease of the information that an SNP provides about the
presence of the disease as a result of knowledge of the other SNP.
Large positive synergy suggests an epistatic interaction
mechanism,asitcanbeseenasapartoftheinformationconveyedby
the pair of SNPs about the presence of the disease that is attributable
to a purely cooperative interaction between the two SNPs. On
the other hand, negative synergy of large magnitude indicates that
the two SNPs are redundantly associated with the presence of the
disease, i.e. each SNP by itself is associated with disease, while
including both SNPs in combination does not signiﬁcantly enhance
this association. For example, multiple pairwise redundant SNPs
may deﬁne a ‘disease-associated haplotype’ when there is a strong
LD connecting these SNPs and all of them appear individually
associated with disease, suggesting that a ‘causal’biological hotspot
may be located within that region.
WecanusetheGWAdatatodeﬁnerandomvariables(three-valued
inthecaseofgenotypedSNPs)bycreatingprobabilisticmodelsfrom
relative frequencies after counting the number of healthy samples
as well as the number of diseased samples encountered in each joint
state. Once we have the model deﬁned, then we can readily evaluate
all the information theoretic quantities directly from these counts
(Anastassiou, 2007; Varadan and Anastassiou, 2006).
When coupled with additional biological knowledge and
validation, SD analysis has the potential to shed light on the nature
of etiological mechanisms, e.g. by analyzing gene product isoforms
from the identiﬁed disease-associated haplotypes or by exploring
known pathways connecting high-synergy genes.
3 EXAMPLES OF SD PLOTS
We used GWA data generated from the Wellcome Trust Case
Control Consortium (WTCCC) including about 2000 cases for
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Fig. 1. (a) SD plot of a disease-related haplotype. (b) SD plot of potential
epistatic interactions between two loci.
each of several diseases and 3004 controls (Wellcome Trust Case
Control Consortium, 2007). These synergies are plotted in a manner
analogous to that used for LD plots, resulting in an SD plot.
For example, Figure 1a shows an SD plot that includes the
SNPs belonging to a coronary artery disease (CAD)-associated
haplotype. The magnitude of synergy of an SNP pair is depicted by
the intensity of the corresponding red diamond-shaped dot, while
the magnitude of the redundancy of an SNP pair is depicted by the
intensity of the corresponding blue diamond-shaped dot. This plot
was generated by considering the region around SNP rs1333049,
which was previously found to be the most strongly associated
with CAD (Wellcome Trust Case Control Consortium, 2007). That
SNP appears at the rightmost end of the haplotype (set of mutually
redundant SNPs with respect to the disease) deﬁned by the blue
entries. Therefore, it is seen that the disease-associated haplotype
extends upstream of rs1333049. In such cases, the precise haplotype
can be easily found from the SD plot by phasing (inferring the
SNPvalues in each chromosome from the genotypes) and analyzing
the corresponding genomic area. The ‘top row’ of dots in SD plots
depicts the ‘self-synergy’ of an SNP with respect to disease, which
measures the SNP’s correlation with disease.
On the other hand, Figure 1b shows an area of potential epistatic
interaction between two genomic regions at different chromosomes
with respect to Crohn’s disease, which we also generated using
the WTCCC data. The plot in Figure 1b is ‘broken’, because it
connects two genomic regions in different chromosomes. The two
high-synergy genomic regions are deﬁned by the high-intensity
red dots.
Another example concerns the known effects of the major
histocompatibility complex class II region, on Type 1 diabetes.
Many susceptible and protective combinations of allelic variations
are known and epistatic interactions between alleles have been
hypothesized(Erlichetal.,2008;Koelemanetal.,2004).Inaddition
to the WTCCC dataset, we obtained an independent validation
dataset from the Type 1 Diabetes Genetics Consortium with 4844
cases and 3552 controls (without any overlap with the 5004 samples
of the WTCCC dataset). After imputing SNP values, we produced
the two corresponding SD plots (Supplementary Figure), which
wereremarkablysimilar,demonstratingthatSDplotsproviderobust
and reliable visual ‘signatures’ depicting aspects of multivariate
correlations with respect to particular phenotypes.
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